69
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

A unique case of donor cell myeloma

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 1839-1841 | Received 07 Sep 2018, Accepted 21 Nov 2018, Published online: 08 Jan 2019

References

  • Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Garcés-Eisele J, et al. Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation: a single institution experience. Leuk Lymphoma. 2006;47:1952–1955.
  • Ruiz-Argüelles GJ, Ruiz-Argüelles A, Garcés-Eisele J. Donor cell leukemia: a critical review. Leuk Lymphoma. 2007;48:25–38.
  • Ruiz-Delgado GJ, Hernández-Reyes J, González-Ramírez MP, et al. Leucemia en células del donador: un estudio prospectivo de su identificación y tratamiento. Gac Méd Méx. 2015;151:582–587.
  • Kim YI, Kim HR, Shin MG, et al. Donor cell origin of multiple myeloma occurring after allogeneic stem cell transplantation in a patient with refractory anemia with ring sideroblast. J Clin Pathol. 2011;64:265–268.
  • Fahkri B, Fiala M, Slade M, et al. Donor-derived smoldering multiple myeloma following a hematopoietic cell transplantation for AML. Case Rep Hematol. 2017;2017:3728429. article ID 3728429.
  • Peri N, Kussick S, Bakthavatsalam R, et al. Postrenal transplant non-EBV multiple myeloma of donor origin. Am J Transplant. 2006;6:419–422.
  • Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989;20:361–369.
  • Kumar A, Styler MJ, Topolsky DL, et al. Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. Am J Hematol. 2002;71:227–228.
  • Maestas E, Jain S, Stiff P. A 54-year-old woman with donor cell origin of multiple myeloma after allogeneic hematopoietic stem cell transplantation for the treatment of CML. Case Rep Hematol. 2016;2016:6751914.
  • Ruiz-Argüelles GJ, Reyes-Núñez V, Garcés-Eisele J, et al. Acquired hemoglobin S trait in an adult patient with secondary acute myelogenous leukemia allografted with matched unrelated umbilical cord blood cells using a non-ablative conditioning regimen. Haema. 2005;8:492–496.
  • Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, et al. Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens. Am J Hematol. 2001;66:241–244.
  • Lawler M, Mc Cann SR. Polymerase chain reaction based methods for assessing chimerism following bone marrow transplantation. In: Cotter FE, editors. Molecular diagnosis of cancer. Totowa (NJ): Humana Press Inc; 1996. p. 105–120.
  • Odriozola A, Riancho JA, Colorado M, et al. Evaluation of the sensitivity of two recently developed STR multiplexes for the analysis of chimerism after haematopoietic stem cell transplantation. Int J Immunogenet. 2013;40:88–92.
  • Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350–1354.
  • Greening DW, Gopal SK, Xu R, et al. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.